QDOLO Trademark

Trademark Overview


On Tuesday, August 11, 2020, a trademark application was filed for QDOLO with the United States Patent and Trademark Office. The USPTO has given the QDOLO trademark a serial number of 90106436. The federal status of this trademark filing is REGISTERED as of Tuesday, December 28, 2021. This trademark is owned by Athena Bioscience, LLC. The QDOLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of and management of pain, premature ejaculation, depression, anxiety, restless leg syndrome, and opioid use disorder
qdolo

General Information


Serial Number90106436
Word MarkQDOLO
Filing DateTuesday, August 11, 2020
Status700 - REGISTERED
Status DateTuesday, December 28, 2021
Registration Number6603833
Registration DateTuesday, December 28, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements


Certificate of Correction for RegistrationIn the statement, line 1, "Pharmaceuticals" should be deleted, and "Bioscience" should be inserted. 
Goods and ServicesPharmaceutical preparations for the treatment of and management of pain, premature ejaculation, depression, anxiety, restless leg syndrome, and opioid use disorder

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 11, 2020
Primary Code005
First Use Anywhere DateMonday, June 11, 2018
First Use In Commerce DateTuesday, September 1, 2020

Trademark Owner History


Party NameAthena Bioscience, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWatkinsville, GA 30677

Party NameAthena Bioscience, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAthens, GA 30601

Party NameAthena Bioscience, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAthens, GA 30601

Trademark Events


Event DateEvent Description
Friday, August 14, 2020NEW APPLICATION ENTERED
Friday, September 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 4, 2020ASSIGNED TO EXAMINER
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, September 9, 2021SOU EXTENSION 1 FILED
Monday, October 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 19, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, October 19, 2021PETITION TO REVIVE-GRANTED
Tuesday, October 19, 2021USE AMENDMENT FILED
Monday, November 15, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 19, 2021TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 19, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, October 20, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, November 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 15, 2021SOU EXTENSION 1 GRANTED
Monday, November 22, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 28, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, September 12, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 17, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Thursday, February 29, 2024TEAS SECTION 7 REQUEST RECEIVED